Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Inhibition of hyaluronan (HA) synthesis protects against CNS autoimmunity and increases CXCL12 expression in the inflamed CNS.
Acute disseminated encephalomyelitis in two renal transplant patients: is there a role for Epstein-Barr virus reactivation?
Descriptive epidemiology of physical activity rates in multiple sclerosis.
IVIg for relapsing-remitting multiple sclerosis: promises and uncertainties.
Reversible pulmonary arterial hypertension associated with interferon-beta treatment for multiple sclerosis.
Dentatorubrothalamic tract localization with postmortem MR diffusion tractography compared to histological 3D reconstruction.
Pulsed corticosteroid treatment in MS patients stabilizes disease activity following natalizumab withdrawal prior to switching to fingolimod.
Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation.
Validation of Social Media Analysis for Outcomes Research: Identification of Drivers of Switches between oral and Injectable Therapies for Multiple Sclerosis.
Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index.
The Effect of Plasma Exchange on the Expression of FOXP3 and RORC2 in Relapsed Multiple Sclerosis Patients.
Editorial Comments: Is multiple sclerosis a neurodegenerative or inflammatory disease?
Uptake of environmental toxicants by the locus ceruleus: A potential trigger for neurodegenerative, demyelinating and psychiatric disorders.
Uphill and Downhill Walking in Multiple Sclerosis: A Randomized Controlled Trial.
Neurological and functional recovery in acute transverse myelitis patients with inpatient rehabilitation and magnetic resonance imaging correlates.
Control of microglial neurotoxicity by the fractalkine receptor.
In Vivo Visualization of (Auto)Immune Processes in the Central Nervous System of Rodents.
Laquinimod therapy in multiple sclerosis: a comprehensive review.
Multiple sclerosis: overview of disease-modifying agents.
Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.
The Correlation between Aquaporin-4 Antibody and the Visual Function of Patients with Demyelinating Optic Neuritis at Onset.
Autoimmune disease: SIRT1 inhibition suppresses multiple sclerosis.
EAE: imperfect but useful models of multiple sclerosis.
The Case | The young philosopher with multiple sclerosis and proteinuria.
Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.
Pages
« first
‹ previous
…
686
687
688
689
690
691
692
693
694
…
next ›
last »